BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28728838)

  • 41. A novel KCNQ2 missense variant in non-syndromic intellectual disability causes mild gain-of-function of Kv7.2 channel.
    Xiong J; Chen S; Chen B; Zhang W; Chen C; Deng X; He F; Zhang C; Yang L; Wang Y; Peng J; Yin F
    Clin Chim Acta; 2022 May; 530():74-80. PubMed ID: 35247435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
    Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropathology findings in KCNQ2 neonatal epileptic encephalopathy.
    Legros L; Adle-Biassette H; Dozières-Puyravel B; Khung S; Elmaleh-Bergès M; Lesca G; Delanoë C; Biran V; Auvin S
    Seizure; 2022 Jul; 99():36-39. PubMed ID: 35584591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Capturing seizures in clinical trials of antiseizure medications for
    Millichap JJ; Harden CL; Dlugos DJ; French JA; Butterfield NN; Grayson C; Aycardi E; Pimstone SN
    Epilepsia Open; 2021 Mar; 6(1):38-44. PubMed ID: 33681646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-throughput evaluation of epilepsy-associated KCNQ2 variants reveals functional and pharmacological heterogeneity.
    Vanoye CG; Desai RR; Ji Z; Adusumilli S; Jairam N; Ghabra N; Joshi N; Fitch E; Helbig KL; McKnight D; Lindy AS; Zou F; Helbig I; Cooper EC; George AL
    JCI Insight; 2022 Mar; 7(5):. PubMed ID: 35104249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.
    Howell KB; McMahon JM; Carvill GL; Tambunan D; Mackay MT; Rodriguez-Casero V; Webster R; Clark D; Freeman JL; Calvert S; Olson HE; Mandelstam S; Poduri A; Mefford HC; Harvey AS; Scheffer IE
    Neurology; 2015 Sep; 85(11):958-66. PubMed ID: 26291284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.
    Weckhuysen S; Mandelstam S; Suls A; Audenaert D; Deconinck T; Claes LR; Deprez L; Smets K; Hristova D; Yordanova I; Jordanova A; Ceulemans B; Jansen A; Hasaerts D; Roelens F; Lagae L; Yendle S; Stanley T; Heron SE; Mulley JC; Berkovic SF; Scheffer IE; de Jonghe P
    Ann Neurol; 2012 Jan; 71(1):15-25. PubMed ID: 22275249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skeletal anomaly and opisthotonus in early-onset epileptic encephalopathy with KCNQ2 abnormality.
    Kawano O; Saito T; Sumitomo N; Takeshita E; Shimizu-Motohashi Y; Nakagawa E; Mizuma K; Tanifuji S; Itai T; Miyatake S; Matsumoto N; Takahashi Y; Mizusawa H; Sasaki M
    Brain Dev; 2023 Apr; 45(4):231-236. PubMed ID: 36631315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP
    Ambrosino P; Freri E; Castellotti B; Soldovieri MV; Mosca I; Manocchio L; Gellera C; Canafoglia L; Franceschetti S; Salis B; Iraci N; Miceli F; Ragona F; Granata T; DiFrancesco JC; Taglialatela M
    Mol Neurobiol; 2018 Aug; 55(8):7009-7024. PubMed ID: 29383681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
    Goto A; Ishii A; Shibata M; Ihara Y; Cooper EC; Hirose S
    Epilepsia; 2019 Sep; 60(9):1870-1880. PubMed ID: 31418850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epilepsy phenotype and response to KCNQ openers in mice harboring the Kcnq2 R207W voltage-sensor mutation.
    Tian F; Cao B; Xu H; Zhan L; Nan F; Li N; Taglialatela M; Gao Z
    Neurobiol Dis; 2022 Nov; 174():105860. PubMed ID: 36113748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-limited alterations in cortical activity of a knock-in mouse model of KCNQ2-related developmental and epileptic encephalopathy.
    Biba-Maazou N; Becq H; Pallesi-Pocachard E; Sarno S; Granjeaud S; Montheil A; Kurz M; Villard L; Milh M; Santini PL; Aniksztejn L
    J Physiol; 2022 May; 600(10):2429-2460. PubMed ID: 35389519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.
    Singh NA; Westenskow P; Charlier C; Pappas C; Leslie J; Dillon J; Anderson VE; Sanguinetti MC; Leppert MF;
    Brain; 2003 Dec; 126(Pt 12):2726-37. PubMed ID: 14534157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene mutation analysis of 175 Chinese patients with early-onset epileptic encephalopathy.
    Zhang Q; Li J; Zhao Y; Bao X; Wei L; Wang J
    Clin Genet; 2017 May; 91(5):717-724. PubMed ID: 27779742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability.
    Miceli F; Striano P; Soldovieri MV; Fontana A; Nardello R; Robbiano A; Bellini G; Elia M; Zara F; Taglialatela M; Mangano S
    Epilepsia; 2015 Feb; 56(2):e15-20. PubMed ID: 25524373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
    Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
    Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early recognition of characteristic conventional and amplitude-integrated EEG patterns of seizures in SCN2A and KCNQ3-related epilepsy in neonates.
    Pijpers JA; Au PYB; Weeke LC; Vein AA; Smit LS; Vilan A; Jacobs E; de Vries LS; Steggerda SJ; Cilio MR; Carapancea E; Cornet MC; Appendino JP; Peeters-Scholte CMPCD
    Seizure; 2023 Aug; 110():212-219. PubMed ID: 37429183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism.
    Miceli F; Millevert C; Soldovieri MV; Mosca I; Ambrosino P; Carotenuto L; Schrader D; Lee HK; Riviello J; Hong W; Risen S; Emrick L; Amin H; Ville D; Edery P; de Bellescize J; Michaud V; Van-Gils J; Goizet C; Willemsen MH; Kleefstra T; Møller RS; Bayat A; Devinsky O; Sands T; Korenke GC; Kluger G; Mefford HC; Brilstra E; Lesca G; Milh M; Cooper EC; Taglialatela M; Weckhuysen S
    EBioMedicine; 2022 Jul; 81():104130. PubMed ID: 35780567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response.
    Numis AL; Angriman M; Sullivan JE; Lewis AJ; Striano P; Nabbout R; Cilio MR
    Neurology; 2014 Jan; 82(4):368-70. PubMed ID: 24371303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De novo KCNQ2 mutations in patients with benign neonatal seizures.
    Claes LR; Ceulemans B; Audenaert D; Deprez L; Jansen A; Hasaerts D; Weckx S; Claeys KG; Del-Favero J; Van Broeckhoven C; De Jonghe P
    Neurology; 2004 Dec; 63(11):2155-8. PubMed ID: 15596769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.